• 513 Citations
  • 14 h-Index
20012019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Marco Vaira is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Drug Therapy Medicine & Life Sciences
Pseudomyxoma Peritonei Medicine & Life Sciences
Carcinoma Medicine & Life Sciences
Ovarian Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Perfusion Medicine & Life Sciences
Morbidity Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2001 2019

  • 513 Citations
  • 14 h-Index
  • 41 Article
  • 2 Chapter
  • 1 Review article

Upfront debulking surgery versus interval debulking surgery for advanced tubo-ovarian high-grade serous carcinoma and diffuse peritoneal metastases treated with peritonectomy procedures plus HIPEC

Biacchi, D., Accarpio, F., Ansaloni, L., Macrì, A., Ciardi, A., Federici, O., Spagnoli, A., Cavaliere, D., Vaira, M., Sapienza, P. & Sammartino, P., Dec 1 2019, In : Journal of Surgical Oncology. 120, 7, p. 1208-1219 12 p.

Research output: Contribution to journalArticle

Patient Selection
Carcinoma
Recurrence
Drug Therapy
Survival
6 Citations (Scopus)

A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: A two- centers experience

Ghisoni, E., Katsaros, D., Maggiorotto, F., Aglietta, M., Vaira, M., De Simone, M., Mittica, G., Giannone, G., Robella, M., Genta, S., Lucchino, F., Marocco, F., Borella, F., Valabrega, G. & Ponzone, R., May 30 2018, In : Journal of Ovarian Research. 11, 1, 42.

Research output: Contribution to journalArticle

Drug Therapy
Disease-Free Survival
Residual Neoplasm
Ovarian epithelial cancer
Neoplasms
Morbidity
Drug Therapy
Mortality
Pseudomyxoma Peritonei
Carcinoma
Pseudomyxoma Peritonei
Complementary Therapies
Aerosols
Drug Therapy
Thorax